Package 62332-419-30

{"route": ["ORAL"], "spl_id": "7c1668c8-101c-4aca-9a03-3b5b9bac1f9e", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0362332419302", "0362332417308", "0362332418305"], "unii": ["U3H27498KS"], "rxcui": ["900156", "1098608", "1146690"], "spl_set_id": ["4bd7193f-a81a-4909-90c2-7f324fc6ddfd"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-419-30)", "package_ndc": "62332-419-30", "marketing_start_date": "20241007"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-419-91)", "package_ndc": "62332-419-91", "marketing_start_date": "20241007"}], "brand_name": "Lamotrigine", "product_id": "62332-419_7c1668c8-101c-4aca-9a03-3b5b9bac1f9e", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "62332-419", "generic_name": "Lamotrigine", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "300 mg/1"}], "application_number": "ANDA211821", "marketing_category": "ANDA", "marketing_start_date": "20241007", "listing_expiration_date": "20261231"}